Verification of Current Risk Scores for Kawasaki Disease in Korean Children
暂无分享,去创建一个
[1] Bo Young Kim,et al. Non-Responders to Intravenous Immunoglobulin and Coronary Artery Dilatation in Kawasaki Disease: Predictive Parameters in Korean Children , 2016, Korean circulation journal.
[2] S. Ohga,et al. Coronary artery lesions and the increasing incidence of Kawasaki disease resistant to initial immunoglobulin. , 2016, International journal of cardiology.
[3] C. Hoggart,et al. Predicting IVIG resistance in UK Kawasaki disease , 2015, Archives of Disease in Childhood.
[4] Sohee Park,et al. Epidemiologic Features of Kawasaki Disease in South Korea: Data from Nationwide Survey, 2009–2011 , 2014, The Pediatric infectious disease journal.
[5] Y. Kashiwagi,et al. Inflammatory cytokines as predictors of resistance to intravenous immunoglobulin therapy in Kawasaki disease patients , 2013, International journal of rheumatic diseases.
[6] Sang Bum Lee,et al. Predictors of nonresponse to intravenous immunoglobulin therapy in Kawasaki disease , 2013, Korean journal of pediatrics.
[7] Z. Du,et al. Novel Predictors of Intravenous Immunoglobulin Resistance in Chinese Children with Kawasaki Disease , 2013, The Pediatric infectious disease journal.
[8] S. Colan,et al. Evaluation of Kawasaki disease risk-scoring systems for intravenous immunoglobulin resistance. , 2011, The Journal of pediatrics.
[9] B. McCrindle,et al. Improved Classification of Coronary Artery Abnormalities Based Only on Coronary Artery z-Scores After Kawasaki Disease , 2010, Pediatric Cardiology.
[10] R. Sundel,et al. Atypical and incomplete Kawasaki disease. , 2009, Best practice & research. Clinical rheumatology.
[11] J. Newburger,et al. Resistance to intravenous immunoglobulin in children with Kawasaki disease. , 2008, The Journal of pediatrics.
[12] S. Kurotobi,et al. Prediction of non-responsiveness to standard high-dose gamma-globulin therapy in patients with acute Kawasaki disease before starting initial treatment , 2006, European Journal of Pediatrics.
[13] T. Matsuishi,et al. Prediction of resistance to intravenous immunoglobulin treatment in patients with Kawasaki disease. , 2006, The Journal of pediatrics.
[14] Tomio Kobayashi,et al. Prediction of Intravenous Immunoglobulin Unresponsiveness in Patients With Kawasaki Disease , 2006, Circulation.
[15] K. Nishigaki,et al. Guidelines for diagnosis and management of cardiovascular sequelae in Kawasaki disease , 2005, Pediatrics international : official journal of the Japan Pediatric Society.
[16] T. Ichiyama,et al. Immunological profile of peripheral blood lymphocytes and monocytes/macrophages in Kawasaki disease , 2005, Clinical and experimental immunology.
[17] Yoshikazu Nakamura,et al. Revision of diagnostic guidelines for Kawasaki disease (the 5th revised edition) , 2005, Pediatrics international : official journal of the Japan Pediatric Society.
[18] K. Harada. Intravenous γ‐Globulin Treatment in Kawasaki Disease , 1991 .
[19] G. Schwartz,et al. Geometric method for measuring body surface area: a height-weight formula validated in infants, children, and adults. , 1978, The Journal of pediatrics.
[20] JCSJointWorkingGroup. Guidelines for diagnosis and management of cardiovascular sequelae in Kawasaki disease (JCS 2013). Digest version. , 2014, Circulation journal : official journal of the Japanese Circulation Society.
[21] K. Harada. Intravenous gamma-globulin treatment in Kawasaki disease. , 1991, Acta paediatrica Japonica : Overseas edition.
[22] T. Enright,et al. Kawasaki syndrome. , 1990, Annals of allergy.